Top Stories
-
Source:
MedscapeIf approved, KarXT— a novel combination of xanomeline with trospium — will be a "landmark" drug, noted Dr. Jeffrey A. Lieberman.
Topic
-
Source:
Medpage TodayDr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
Topic
-
The Horga Lab is a psychiatry research lab that uses neuroimaging and cognitive methods to study the origins of the psychotic symptoms of schizophrenia, including hallucinations and delusions.
Topic
-
Columbia researchers have published their first report on mass shootings from the Columbia Mass Murder Database (CMMD).
Topic
Latest News
-
Source:
NewsDayFebruary 8, 2020“For some people, this illness is highly disabling, but there’s a significant number of people who have this illness who are able to live very fulfilling lives,” said Dr. Lisa Dixon.
Topic
-
Source:
Washington PostJanuary 13, 2020“Ultimately we want to identify people who are at risk before onset and try to prevent the development of psychosis,” says Dr. Lisa Dixon.
Topic
-
Source:
MD MagazineJanuary 8, 2020In an accompanying editorial, Dr. Joshua T. Kantrowitz explained how the future role of lumateperone could be crucial in treating schizophrenia patients.
Topic
-
Source:
MD MagazineDecember 23, 2019“The efficacy and safety profile of CAPLYTA approved by the FDA, offers healthcare providers an important new option for treating people living with schizophrenia,” said Dr. Jeffrey A. Lieberman.
Topic
-
Source:
MedscapeSeptember 12, 2019Drs. Drew Ramsey and Lisa B. Dixon discuss first-episode psychosis and effective interventions.
Topic
- August 28, 2019
Dr. Gary Brucato, the Center of Prevention and Evaluation's Assistant Director, breaks down some of the early warning signs and symptoms of possible emergent psychotic illness.
Topic
-
Source:
Psychiatry & Behavioral Health Learning NetworkAugust 14, 2019This study “adds to a growing literature of using electrophysiological outcomes, including mismatch negativity as predictive biomarkers,” commented Dr. Joshua Kantrowitz.
Topic
- May 31, 2019
In this first episode of Inside Schizophrenia, Rachel Star Withers, a diagnosed schizophrenic, co-host Gabe Howard and special guest Dr. Ali Mattu explore this often misrepresented mental illness.
Topic
- April 15, 2019
Columbia Psychiatrists suggest that researchers, pharmaceutical companies, and the FDA reconsider placebo-controlled, relapse prevention studies in schizophrenia.
Topic
-
Source:
JAMAApril 10, 2019Dr. Jeffrey Lieberman and colleagues conclude that the time has come to cease the use of placebo in relapse prevention studies and encourage the use of active comparators.
Topic
